Elutia (ELUT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.79, +0.63% vs the prior close of $0.79.
- Volume 86.60K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ELUT rises 0.6% to $0.79. Closed at $0.79, +0.63% vs the prior close of $0.79. Day range $0.74–$0.81, opened at $0.80.
ELUT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ELUT rises 0.6% to $0.79
- Closed at $0.79, +0.63% vs the prior close of $0.79. Day range $0.74–$0.81, opened at $0.80.
- Volume was 86.60K shares, 0.4x its 50-day average of 210.87K — lighter than usual.
- Price is -5.8% vs its 50-day average ($0.84) and -18.0% vs its 200-day average ($0.97).
- 52-week range $0.50–$1.38; today's close sits at 33% of that range, 42.7% below the 52-week high.
Oct 15, 2026 — ELUT jumps 7.3% to $0.79
- Closed at $0.79, +7.35% vs the prior close of $0.74. Day range $0.71–$0.80, opened at $0.72.
- Volume was 123.90K shares, 0.6x its 50-day average of 209.18K — lighter than usual.
- Price is -6.6% vs its 50-day average ($0.84) and -18.4% vs its 200-day average ($0.97).
- 52-week range $0.50–$1.38; today's close sits at 33% of that range, 43.0% below the 52-week high.
Oct 14, 2026 — ELUT slides 4.9% to $0.74, a 6-month low, 4 down days in a row
- Closed at $0.74, -4.92% vs the prior close of $0.77. Day range $0.72–$0.81, opened at $0.79.
- Volume was 293.10K shares, 1.4x its 50-day average of 203.88K.
- Price is -13.1% vs its 50-day average ($0.85) and -23.9% vs its 200-day average ($0.97).
- 52-week range $0.50–$1.38; today's close sits at 27% of that range, 46.9% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — ELUT dips 1.8% to $0.77, a 6-month low, 3 down days in a row
- Closed at $0.77, -1.78% vs the prior close of $0.79. Day range $0.76–$0.80, opened at $0.78.
- Volume was 36.60K shares, 0.2x its 50-day average of 203.98K — lighter than usual.
- Price is -8.9% vs its 50-day average ($0.85) and -19.9% vs its 200-day average ($0.96).
- 52-week range $0.50–$1.38; today's close sits at 31% of that range, 44.2% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — ELUT slides 4.4% to $0.79
- Closed at $0.79, -4.37% vs the prior close of $0.82. Day range $0.76–$0.80, opened at $0.79.
- Volume was 69.80K shares, 0.3x its 50-day average of 205.79K — lighter than usual.
- Price is -7.5% vs its 50-day average ($0.85) and -18.4% vs its 200-day average ($0.96).
- 52-week range $0.50–$1.38; today's close sits at 32% of that range, 43.2% below the 52-week high.
Oct 9, 2026 — ELUT dips 0.5% to $0.82
- Closed at $0.82, -0.48% vs the prior close of $0.83. Day range $0.79–$0.83, opened at $0.82.
- Volume was 19.70K shares, 0.1x its 50-day average of 206.79K — lighter than usual.
- Price is -3.4% vs its 50-day average ($0.85) and -14.5% vs its 200-day average ($0.96).
- 52-week range $0.50–$1.38; today's close sits at 36% of that range, 40.6% below the 52-week high.
Oct 8, 2026 — ELUT rises 0.9% to $0.83
- Closed at $0.83, +0.85% vs the prior close of $0.82. Day range $0.82–$0.83, opened at $0.82.
- Volume was 115.30K shares, 0.6x its 50-day average of 205.04K — lighter than usual.
- Price is -3.1% vs its 50-day average ($0.85) and -14.0% vs its 200-day average ($0.96).
- 52-week range $0.50–$1.38; today's close sits at 37% of that range, 40.3% below the 52-week high.
Oct 7, 2026 — ELUT jumps 5.5% to $0.82
- Closed at $0.82, +5.53% vs the prior close of $0.78. Day range $0.77–$0.84, opened at $0.79.
- Volume was 261.00K shares, 1.3x its 50-day average of 200.29K.
- Price is -4.1% vs its 50-day average ($0.85) and -14.6% vs its 200-day average ($0.96).
- 52-week range $0.50–$1.38; today's close sits at 36% of that range, 40.8% below the 52-week high.
Oct 6, 2026 — ELUT slides 5.5% to $0.78, a 6-month low
- Closed at $0.78, -5.47% vs the prior close of $0.82. Day range $0.77–$0.83, opened at $0.81.
- Volume was 281.80K shares, 1.4x its 50-day average of 195.09K.
- Price is -9.3% vs its 50-day average ($0.86) and -19.0% vs its 200-day average ($0.96).
- 52-week range $0.50–$1.38; today's close sits at 31% of that range, 43.9% below the 52-week high.
Oct 5, 2026 — ELUT jumps 5.5% to $0.82
- Closed at $0.82, +5.52% vs the prior close of $0.78. Day range $0.72–$0.83, opened at $0.78.
- Volume was 255.10K shares, 1.3x its 50-day average of 191.34K.
- Price is -4.5% vs its 50-day average ($0.86) and -14.1% vs its 200-day average ($0.96).
- 52-week range $0.50–$1.38; today's close sits at 36% of that range, 40.6% below the 52-week high.
Oct 2, 2026 — ELUT dips 2.6% to $0.78, a 6-month low on 7.8x normal volume
- Closed at $0.78, -2.63% vs the prior close of $0.80. Day range $0.67–$0.82, opened at $0.78.
- Volume was 1.30M shares, 7.8x its 50-day average of 166.32K — unusually heavy trading.
- Price is -9.7% vs its 50-day average ($0.86) and -18.5% vs its 200-day average ($0.96).
- 52-week range $0.50–$1.38; today's close sits at 32% of that range, 43.8% below the 52-week high.
ELUT latest news & SEC filings
Every SEC filing by or about ELUT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$7.65M (prior year -$9.61M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.17 (prior year -$0.26) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 11, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Jul 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade ELUT
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 11, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.14% (largest 7.3%). That is a volatile stock.
- Liquidity: about 454.77K shares (≈$361.09K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.79 vs a range of $0.50–$1.38 (33% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Kevin Rakin bought 70,000 shares on Jan 30, 2026.
- Latest filings: 8-K Aug 21, 2026; 10-Q Aug 14, 2026; 8-K Aug 13, 2026.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
ELUT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.80 | 0.81 | 0.74 | 0.79 | 86.60K |
| Oct 15, 2026 | 0.72 | 0.80 | 0.71 | 0.79 | 123.90K |
| Oct 14, 2026 | 0.79 | 0.81 | 0.72 | 0.74 | 293.10K |
| Oct 13, 2026 | 0.78 | 0.80 | 0.76 | 0.77 | 36.60K |
| Oct 12, 2026 | 0.79 | 0.80 | 0.76 | 0.79 | 69.80K |
| Oct 9, 2026 | 0.82 | 0.83 | 0.79 | 0.82 | 19.70K |
| Oct 8, 2026 | 0.82 | 0.83 | 0.82 | 0.83 | 115.30K |
| Oct 7, 2026 | 0.79 | 0.84 | 0.77 | 0.82 | 261.00K |
| Oct 6, 2026 | 0.81 | 0.83 | 0.77 | 0.78 | 281.80K |
| Oct 5, 2026 | 0.78 | 0.83 | 0.72 | 0.82 | 255.10K |
| Oct 2, 2026 | 0.78 | 0.82 | 0.67 | 0.78 | 1.30M |
| Oct 1, 2026 | 0.79 | 0.81 | 0.79 | 0.80 | 6.05M |
| Sep 30, 2026 | 0.79 | 0.81 | 0.79 | 0.79 | 21.90K |
| Sep 29, 2026 | 0.80 | 0.82 | 0.79 | 0.79 | 11.50K |
| Sep 28, 2026 | 0.82 | 0.83 | 0.81 | 0.81 | 5.60K |
| Sep 25, 2026 | 0.82 | 0.83 | 0.81 | 0.82 | 34.70K |
| Sep 24, 2026 | 0.90 | 0.90 | 0.82 | 0.83 | 16.30K |
| Sep 23, 2026 | 0.85 | 0.88 | 0.85 | 0.87 | 19.70K |
| Sep 22, 2026 | 0.85 | 0.85 | 0.80 | 0.81 | 64.90K |
| Sep 21, 2026 | 0.85 | 0.87 | 0.85 | 0.85 | 23.20K |
About Elutia
Elutia (ELUT) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in SILVER SPRING, MD. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1708527.
ELUT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David Colpman | Director | Jun 15, 2026 |
| Brigid Makes | Director | Jun 15, 2026 |
| C Randal Mills | PRESIDENT AND CEO | Sep 14, 2026 |
| Guido J Neels | Director | Jun 15, 2026 |
| Kevin Rakin | Director | Jun 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Matthew Ferguson | CHIEF FINANCIAL OFFICER | Sep 14, 2026 |
| C Randal Mills | PRESIDENT AND CEO | Sep 14, 2026 |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Sep 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jan 30, 2026 | Kevin Rakin | Buy | 70,000 | $1.06 |
| Jan 30, 2026 | Kevin Rakin | Buy | 70,000 | $1.06 |
| Jan 30, 2026 | Partners Qp Ii, L.P. Highcape | Buy | 70,000 | $1.06 |
| Jan 30, 2026 | Partners Qp Ii, L.P. Highcape | Buy | 70,000 | $1.06 |
| Jan 30, 2026 | Partners Gp Ii, L.P. Highcape | Buy | 70,000 | $1.06 |
| Jan 30, 2026 | Partners Gp Ii, L.P. Highcape | Buy | 70,000 | $1.06 |
| Jan 30, 2026 | Partners Gp Ii, Llc Highcape | Buy | 70,000 | $1.06 |
| Jan 30, 2026 | Partners Gp Ii, Llc Highcape | Buy | 70,000 | $1.06 |
| Jan 30, 2026 | Kevin Rakin | Buy | 70,000 | $1.06 |
| Jan 30, 2026 | Kevin Rakin | Buy | 70,000 | $1.06 |
| Jan 30, 2026 | Partners Qp Ii, L.P. Highcape | Buy | 70,000 | $1.06 |
| Jan 30, 2026 | Partners Qp Ii, L.P. Highcape | Buy | 70,000 | $1.06 |
| Jan 30, 2026 | Partners Gp Ii, L.P. Highcape | Buy | 70,000 | $1.06 |
| Jan 30, 2026 | Partners Gp Ii, L.P. Highcape | Buy | 70,000 | $1.06 |
| Jan 30, 2026 | Partners Gp Ii, Llc Highcape | Buy | 70,000 | $1.06 |
ELUT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $53.38M | 0.87 | $-44.81M |
| Dec 31, 2024 | — | $-53.95M | -1.86 | $-22.66M |
| Dec 31, 2023 | — | $-37.66M | -2.07 | $-21.76M |
| Dec 31, 2022 | — | $-32.90M | -2.38 | $-21.43M |
| Dec 31, 2021 | — | $-24.83M | -2.38 | $-15.45M |
Latest balance sheet: total assets $43.65M, total liabilities $27.90M, cash $19.90M (as of Jun 30, 2026).
ELUT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $0.86 |
| May 14, 2026 | 8-K Item 2.02 (results) | $1.04 |
| Mar 11, 2026 | 8-K Item 2.02 (results) | $1.09 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $0.69 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $0.94 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $2.15 |
| May 8, 2025 | 8-K Item 2.02 (results) | $1.99 |
| Mar 6, 2025 | 8-K Item 2.02 (results) | $2.55 |
| Feb 3, 2025 | 8-K Item 2.02 (results) | $2.76 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $3.83 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ELUT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.